We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 18, 2021

Clinical Outcomes and Toxic Effects of Single-Agent ICIs Among Older Cancer Patients

JAMA Oncology


Additional Info

JAMA Oncology
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study
JAMA Oncol 2021 Nov 04;[EPub Ahead of Print], CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, N Debnath, A Saeed, M Radford, A Alahmadi, A Diamond, C Hoimes, N Ramaiya, CJ Presley, DH Owen, S Abou Alaiwi, A Nassar, B Ricciuti, G Lamberti, M Bersanelli, C Casartelli, S Buti, P Marchetti, R Giusti, M Filetti, V Vanella, D Mallardo, S Macherla, TA Sussman, A Botticelli, D Galetta, A Catino, P Pizzutilo, C Genova, MG Dal Bello, F Kalofonou, E Daniels, PA Ascierto, DJ Pinato, TK Choueiri, DB Johnson, TU Marron, Y Wang, AR Naqash

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading